Adhera Therapeutics, Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Adhera Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2023.
  • Adhera Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2023 was 19 %, a 27.3% increase year-over-year.
  • Adhera Therapeutics, Inc. annual Return On Equity for 2022 was 9.45 %, a 71.3% decline from 2021.
  • Adhera Therapeutics, Inc. annual Return On Equity for 2021 was 32.9 %, a 17.3% increase from 2020.
  • Adhera Therapeutics, Inc. annual Return On Equity for 2020 was 28.1 %, a 89.8% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 19 +4.08 +27.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 12.3 -11.5 -48.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 13.4 -14.1 -51.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 9.45 -23.5 -71.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 14.9 -16 -51.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 23.7 +10.8 +82.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 27.5 +11.1 +67.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 32.9 +4.86 +17.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 30.9 -29.4 -48.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 13 -80.4 -86.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 16.4 -136 -89.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 28.1 -247 -89.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 60.3 -887 -93.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 93.4 +1.02K Apr 1, 2020 Jun 30, 2020
Q1 2020 152 +485 Jan 1, 2020 Mar 31, 2020
Q4 2019 275 +604 Oct 1, 2019 Dec 31, 2019
Q3 2019 947 +1.32K Jul 1, 2019 Sep 30, 2019
Q2 2019 -931 -633 -213% Apr 1, 2019 Jun 30, 2019
Q1 2019 -333 +358 +51.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -329 -16.8 -5.39% Oct 1, 2018 Dec 31, 2018
Q3 2018 -375 -236 -171% Jul 1, 2018 Sep 30, 2018
Q2 2018 -297 -189 -175% Apr 1, 2018 Jun 30, 2018
Q1 2018 -691 -612 -773% Jan 1, 2018 Mar 31, 2018
Q4 2017 -312 -265 -569% Oct 1, 2017 Dec 31, 2017
Q3 2017 -139 +279 +66.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 -108 +366 +77.2% Apr 1, 2017 Jun 30, 2017
Q1 2017 -79.2 -576 -116% Jan 1, 2017 Mar 31, 2017
Q4 2016 -46.6 -115 -168% Oct 1, 2016 Dec 31, 2016
Q3 2016 -417 +107 +20.4% Jul 1, 2016 Sep 30, 2016
Q2 2016 -474 -474 -968751% Apr 1, 2016 Jun 30, 2016
Q1 2016 496 +567 Jan 1, 2016 Mar 31, 2016
Q4 2015 68.7 -55.8 -44.8% Oct 1, 2015 Dec 31, 2015
Q3 2015 -524 -729 -356% Jul 1, 2015 Sep 30, 2015
Q2 2015 0.05 -142 -100% Apr 1, 2015 Jun 30, 2015
Q1 2015 -70.3 -273 -135% Jan 1, 2015 Mar 31, 2015
Q4 2014 124 +94 +309% Oct 1, 2014 Dec 31, 2014
Q3 2014 204 +128 +168% Jul 1, 2014 Sep 30, 2014
Q2 2014 142 +33.8 +31.2% Apr 1, 2014 Jun 30, 2014
Q1 2014 203 +108 +113% Jan 1, 2014 Mar 31, 2014
Q4 2013 30.5 -260 -89.5% Oct 1, 2013 Dec 31, 2013
Q3 2013 76.3 -1.17K -93.9% Jul 1, 2013 Sep 30, 2013
Q2 2013 108 +1.07K Apr 1, 2013 Jun 30, 2013
Q1 2013 95.3 +519 Jan 1, 2013 Mar 31, 2013
Q4 2012 290 Oct 1, 2012 Dec 31, 2012
Q3 2012 1.24K Jul 1, 2012 Sep 30, 2012
Q2 2012 -967 Mar 31, 2012 Jun 30, 2012
Q1 2012 -423 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.